Assessment of the transformation of equine skin-derived fibroblasts to multinucleated skeletal myotubes following lentiviral-induced expression of equine myogenic differentiation 1

American Journal of Veterinary Research

Volumn 69, Issue 12, 2008, Pages 1637-1645

  Fernandez Fuente, Marta ^a   Ames, Elizabeth G ^c   Wagner, Michelle L ^c   Zhou, Haiyan ^b   Strom, Molly ^d   Zammit, Peter S ^e   Mickelson, James R ^c   Muntoni, Francesco ^b   Brown, Susan C ^b   Piercy, Richard J ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DESMIN; ENHANCED GREEN FLUORESCENT PROTEIN; GLYCOGEN; MESSENGER RNA; MYOD1 PROTEIN; MYOSIN; TROPONIN T;

ANIMAL CELL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL DIFFERENTIATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC TRANSFECTION; GENOME ANALYSIS; HORSE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERNAL RIBOSOME ENTRY SITE; LENTIVIRINAE; MULTINUCLEAR CELL; MYOPATHY; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIODIC ACID SCHIFF STAIN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SKELETAL MUSCLE; SKIN FIBROBLAST; TISSUE SPECIFICITY; VIRUS INDUCTION; WESTERN BLOTTING;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; FIBROBLASTS; GENE EXPRESSION REGULATION; HORSES; HUMANS; LENTIVIRUS; MICE; MOLECULAR SEQUENCE DATA; MUSCLE FIBERS, SKELETAL; MYOD PROTEIN; SKIN;

BACTERIA (MICROORGANISMS); EQUIDAE; MAMMALIA;

EID: 57849112357     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.12.1637     Document Type: Article

References (33)

1. Cole FL, Mellor DJ, Hodgson DR, et al. Prevalence and demographic characteristics of exertional rhabdomyolysis in horses in Australia. Vet Rec 2004;155:625-630.
2. MacLeay JM, Sorum SA, Valberg SJ, et al. Epidemiologic analysis of factors influencing exertional rhabdomyolysis in Thorough-breds. Am J Vet Res 1999;60:1562-1566.
3. Upjohn MM, Archer RM, Christley RM, et al. Incidence and risk factors associated with exertional rhabdomyolysis syndrome in National Hunt racehorses in Great Britain. Vet Rec 2005;156:763-766.
4. McCue ME, Valberg SJ. Estimated prevalence of polysaccharide storage myopathy among overtly healthy Quarter Horses in the United States. J Am Vet Med Assoc 2007;231:746-750.
5. Firshman AM, Baird JD, Valberg SJ. Prevalences and clinical signs of polysaccharide storage myopathy and shivers in Belgian draft horses. J Am Vet Med Assoc 2005;227:1958-1964.
6. Ducreux S, Zorzato F, Muller C, et al. Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease. J Biol Chem 2004;279:43838-43846.
7. Lentz LR, Valberg SJ, Herold LV, et al. Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis. Am J Vet Res 2002;63:1724-1731.
8. Zammit P, Beauchamp J. The skeletal muscle satellite cell: stem cell or son of stem cell? Differentiation 2001;68:193-204.
9. Zacharias JM, Anderson JE. Muscle regeneration after imposed injury is better in younger than older mdx dystrophic mice. J Neurol Sci 1991;104:190-196.
10. Blau HM, Webster C, Chiu CP, et al. Differentiation properties of pure populations of human dystrophic muscle cells. Exp Cell Res 1983;144:495-503.
11. Blau HM, Webster C, Pavlath GK. Defective myoblasts identified in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 1983;80:4856-4860.
12. Choi J, Costa ML, Mermelstein CS, et al. MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc Natl Acad Sci U S A 1990;87:7988-7992.
13. Weintraub H, Tapscott SJ, Davis RL, et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A 1989;86:5434-5438.
14. Huard C, Moisset PA, Dicaire A, et al. Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles. Biochem Biophys Res Commun 1998;248:648-654.
15. Lattanzi L, Salvatori G, Coletta M, et al. High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest 1998;101:2119-2128.
16. Zhou H, Yamaguchi N, Xu L, et al. Characterization of recessive RYR1 mutations in core myopathies. Hum Mol Genet 2006;15:2791-2803.
17. Cooper ST, Kizana E, Yates JD, et al. Dystrophinopathy carrier determination and detection of protein deficiencies in muscular dystrophy using lentiviral MyoD-forced myogenesis. Neuromuscul Disord 2007;17:276-284.
18. Zufferey R, Nagy D, Mandel RJ, et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997;15:871-875.
19. Bock M, Bishop KN, Towers G, et al. Use of a transient assay for studying the genetic determinants of Fv1 restriction. J Virol 2000;74:7422-7430.
20. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987;51:987-1000.
21. Berkes CA, Tapscott SJ. MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol 2005;16:585-595.
22. Braun T, Buschhausen-Denker G, Bober E, et al. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J 1989;8:701-709.
23. Stewart NT, Byrne KM, Ragle CA, et al. Patterns of expression of muscle-specific markers of differentiation in satellite cell cultures: determination by enzyme-linked immunoculture assay and confocal immunofluorescent assay. Cell Biol Int 2001;25:873-884.
24. Wang Y, Jaenisch R. Myogenin can substitute for Myf5 in promoting myogenesis but less efficiently. Development 1997;124:2507-2513.
25. Rawls A, Morris JH, Rudnicki M, et al. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis. Dev Biol 1995;172:37-50.
26. Hidaka C, Milano E, Leopold PL, et al. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Invest 1999;103:579-587.
27. Ishihara A, Zachos TA, Bartlett JS, et al. Evaluation of permissiveness and cytotoxic effects in equine chondrocytes, synovial cells, and stem cells in response to infection with adenovirus 5 vectors for gene delivery. Am J Vet Res 2006;67:1145-1155.
28. Ross SA, Song X, Burney MW, et al. Efficient adenovirus transduction of 3T3-L1 adipocytes stably expressing coxsackie-adenovirus receptor. Biochem Biophys Res Commun 2003;302:354-358.
29. Fouletier-Dilling CM, Bosch P, Davis AR, et al. Novel compound enables high-level adenovirus transduction in the absence of an adenovirus-specific receptor. Hum Gene Ther 2005;16:1287-1297.
30. Musaro A, Cusella De Angelis MG, Germani A, et al. Enhanced expression of myogenic regulatory genes in aging skeletal muscle. Exp Cell Res 1995;221:241-248.
31. Valberg SJ, Cardinet III GH, Carlson GP, et al. Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses. Neuromuscul Disord 1992;2:351-359.
32. Beech J, Lindborg S, Fletcher JE, et al. Caffeine contractures, twitch characteristics and the threshold for Ca(2+)-induced Ca2+ release in skeletal muscle from horses with chronic intermittent rhabdomyolysis. Res Vet Sci 1993;54:110-117.
33. Lentz LR, Valberg SJ, Balog EM, et al. Abnormal regulation of muscle contraction in horses with recurrent exertional rhabdomyolysis. Am J Vet Res 1999;60:992-999.